Recent Quarter Total Invested
$1.97 B
Recent Quarter Institutional Ownership Percentage
54.1%
Total Invested of Last Quarter
$2.25 B
Ownership Percentage of Last Quarter
48.22%
Immunovant, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| FMR LLC | 08/13/2024 | 10.48 M | $276.77 M | 36.94% | 7.59% |
| VANGUARD GROUP INC | 08/13/2024 | 6.51 M | $171.86 M | 0.49% | 4.71% |
| BLACKROCK INC. | 08/13/2024 | 4.92 M | $129.79 M | 9.81% | 3.56% |
| ARMISTICE CAPITAL, LLC | 08/14/2024 | 3.40 M | $89.68 M | 56.97% | 2.46% |
| DEEP TRACK CAPITAL, LP | 08/14/2024 | 2.88 M | $76.13 M | 484.52% | 2.09% |
| STATE STREET CORP | 08/14/2024 | 2.72 M | $71.78 M | -25.34% | 1.97% |
| VIKING GLOBAL INVESTORS LP | 08/14/2024 | 2.32 M | $61.27 M | 28.29% | 1.68% |
| PERCEPTIVE ADVISORS LLC | 08/16/2024 | 1.92 M | $50.79 M | -35.08% | 1.39% |
| ALPINE GLOBAL MANAGEMENT, LLC | 08/14/2024 | 1.91 M | $50.36 M | 1.33% | 1.38% |
| WOODLINE PARTNERS LP | 08/14/2024 | 1.82 M | $48.14 M | 41.40% | 1.32% |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 08/14/2024 | 1.63 M | $42.91 M | 100.00% | 1.18% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/09/2024 | 1.41 M | $37.34 M | 7.38% | 1.02% |
| PARADIGM BIOCAPITAL ADVISORS LP | 08/14/2024 | 1.36 M | $35.98 M | 70.56% | 0.99% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 08/14/2024 | 1.36 M | $35.95 M | -26.87% | 0.99% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 08/14/2024 | 1.19 M | $31.30 M | 3.09% | 0.86% |
| PICTET ASSET MANAGEMENT HOLDING SA | 08/13/2024 | 1.17 M | $31.02 M | -7.15% | 0.85% |
| NUVEEN ASSET MANAGEMENT, LLC | 08/09/2024 | 1.14 M | $30.22 M | 3.67% | 0.83% |
| FRANKLIN RESOURCES INC | 08/14/2024 | 1.10 M | $29.09 M | 26.77% | 0.80% |
| STEMPOINT CAPITAL LP | 08/13/2024 | 1.01 M | $26.71 M | 61.33% | 0.73% |
| CAPITAL RESEARCH GLOBAL INVESTORS | 08/13/2024 | 976,237 | $25.77 M | 0.00% | 0.71% |
| AVIDITY PARTNERS MANAGEMENT LP | 08/14/2024 | 908,000 | $23.97 M | 79.80% | 0.66% |
| BOXER CAPITAL, LLC | 08/14/2024 | 825,000 | $21.78 M | 0.00% | 0.60% |
| MORGAN STANLEY | 10/17/2024 | 817,038 | $21.57 M | -12.89% | 0.59% |
| COMMODORE CAPITAL LP | 08/14/2024 | 750,990 | $19.83 M | 0.00% | 0.54% |
| REDMILE GROUP, LLC | 08/14/2024 | 720,177 | $19.01 M | -25.73% | 0.52% |
| FIRST TURN MANAGEMENT, LLC | 08/08/2024 | 695,428 | $18.36 M | 35.59% | 0.50% |
| TWO SEAS CAPITAL LP | 08/14/2024 | 692,406 | $18.28 M | 27.92% | 0.50% |
| FRED ALGER MANAGEMENT, LLC | 08/14/2024 | 607,724 | $16.04 M | -52.21% | 0.44% |
| NORGES BANK | 08/14/2024 | 601,861 | $15.89 M | 100.00% | 0.44% |
| LOGOS GLOBAL MANAGEMENT LP | 08/27/2024 | 575,000 | $15.18 M | -67.61% | 0.42% |
| INVESCO LTD. | 08/13/2024 | 570,898 | $15.07 M | 8.49% | 0.41% |
| PRINCIPAL FINANCIAL GROUP INC | 07/29/2024 | 559,688 | $14.78 M | -3.95% | 0.41% |
| DIMENSIONAL FUND ADVISORS LP | 08/09/2024 | 494,689 | $13.06 M | -13.73% | 0.36% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 08/13/2024 | 476,543 | $12.58 M | 684.27% | 0.35% |
| PFM HEALTH SCIENCES, LP | 08/14/2024 | 472,540 | $12.48 M | 0.00% | 0.34% |
| BAKER BROS. ADVISORS LP | 08/14/2024 | 464,718 | $12.27 M | 9.34% | 0.34% |
| NORTHERN TRUST CORP | 08/14/2024 | 463,721 | $12.24 M | -3.13% | 0.34% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/12/2024 | 461,171 | $12.17 M | 4.32% | 0.33% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 08/14/2024 | 420,000 | $11.09 M | 320.00% | 0.30% |
| GOLDMAN SACHS GROUP INC | 08/13/2024 | 411,918 | $10.87 M | 17.97% | 0.30% |
| ABRDN PLC | 08/09/2024 | 400,722 | $10.58 M | 113.56% | 0.29% |
| RENAISSANCE TECHNOLOGIES LLC | 08/09/2024 | 388,100 | $10.25 M | 14.25% | 0.28% |
| NOMURA HOLDINGS INC | 08/14/2024 | 360,000 | $9.50 M | 620.00% | 0.26% |
| AFFINITY ASSET ADVISORS, LLC | 08/14/2024 | 346,088 | $9.14 M | 21.43% | 0.25% |
| CITADEL ADVISORS LLC | 08/14/2024 | 343,512 | $9.07 M | 50.33% | 0.25% |
| PROSIGHT MANAGEMENT, LP | 08/14/2024 | 325,000 | $8.58 M | 66.67% | 0.24% |
| UBS ASSET MANAGEMENT AMERICAS INC | 08/14/2024 | 320,508 | $8.46 M | 55.56% | 0.23% |
| VICTORY CAPITAL MANAGEMENT INC | 08/05/2024 | 312,370 | $8.25 M | -2.08% | 0.23% |
| ASSENAGON ASSET MANAGEMENT S.A. | 07/18/2024 | 311,525 | $8.22 M | 198.05% | 0.23% |
| EMERALD ADVISERS, LLC | 08/06/2024 | 288,564 | $7.62 M | -4.70% | 0.21% |
Immunovant, Inc.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of IMVT shares?
During the previous two years, 216 institutional investors and hedge funds held shares of Immunovant, Inc.. The most heavily invested institutionals were:
Harbour Capital Advisors, LLC: 0
PRINCIPAL SECURITIES, INC.: 0
LOS ANGELES CAPITAL MANAGEMENT LLC: 0
INNEALTA CAPITAL, LLC: 0
Allspring Global Investments Holdings, LLC: 0
Assenagon Asset Management S.A.: 0
-
What percentage of Immunovant, Inc. stock is owned by institutional investors?
54.10% of Immunovant, Inc. stock is owned by institutional investors.
-
How much institutional buying is happening at IMVT ?
Institutional investors have bought a total of 75.35 M shares in the last 24 months. This purchase volume represents approximately $2.23 B in transactions.